Novel water soluble half-sandwich complexes of the general formulae [M(g 6 -p-cym)(ha)] 2 (CF 3 SO 3 ) 2 , [M(g 6 -p-cym)(ha)Cl] or [M(g 6 -p-cym)(ha)(py)]X (M = Os, Ru; ha = hydroxamate; py = pyridine; X = Cl 2 or CF 3 SO 3 2 ), incorporating metal-containing entities and hydroxamates both with potential anti-proliferative features, were prepared and characterized by elemental analysis, spectroscopy (NMR, IR) and ESI mass spectrometry. The X-ray crystal structure of (17) occurs, and the crystal and molecular structure has been determined by X-ray method. Complexes 1, 5-8, 10 and 14 were tested for their in vitro cytotoxicity, using human-derived ovarian cancer cell lines (A2780 and A2780 cisR), and showed no anti-proliferative effect in the concentration range (0-200 mM) studied.
Introduction
Hydroxamic acids, R 1 CON(R 2 )OH, are an important class of biomolecules, capable of forming stable five-membered (O,O) chelates with a wide range of metal ions. This strong interaction may result in an essential role for these ligands in terms of uptake and transport of different metal ions, e.g. Fe 3+ , mainly in microorganisms, or in the effective and selective inhibition of various metalloenzymes. 1 Based on the inhibition of histone deacetylases, a monohydroxamic acid, suberoilanilide hydroxamic acid (sahaH), is currently undergoing clinical use as a treatment for cutaneous T-cell lymphoma. 2, 3 Half-sandwich Ru(II) complexes with promising anti-proliferative properties have also been the subject of intensive research in recent decades. Among others, the effects of the size and hydrophobicity of the g 6 -arene, the type of the coordinated (N,N) (N,O) or (O,O) chelating ligands, the rate of aquation of the monodentate ligand at the sixth coordination site, and the acidity of the water molecule after aquation have all been studied on the in vitro cytotoxicity of the complexes. [4] [5] [6] [7] We have hypothesized that a combination of the two entities, namely hydroxamate and [Ru II (g 6 -arene)], into one molecule may result in the production of molecules with beneficial properties. 8, 9 Indeed, preliminary results have shown that [Ru(g 6 -p-cym)-(saha)Cl] has moderate cytotoxicity (IC 50 = 85 mM) against two ovarian cancer cell lines, namely A2780 and A2780 cisR. 10 However, significantly less is known about the corresponding osmium complexes with the [Os II (g 6 -arene)] entity. Half-sandwich osmium(II) compounds with (N,N) [11] [12] [13] [14] (N,O) 15, 16 or (O,O) 11, 17 chelating ligands have been synthesized and tested against different cancer cell lines. In particular, acetylacetonato 11 or maltolato 17 containing complexes, [Os(g 6 -p-cym)(O,O)Cl], were found to be capable of fast ligand exchange in aqueous solution, resulting in the formation of an inactive hydroxo species at physiological pH. In the case of hydroxamates as (O,O) donors interacting with any forms of Os, only one report was found in the literature. Here, a reaction of [Os II (bpy) 2 Br 2 ] (bpy = 2,29-bipyridine) with N-arylbenzohydroxamic acids produced a cyclometalate of Os(III). The benzanilide which was formed from the hydroxamate coordinated as a dianionic C,N-donor. 18 To our that the rate is 3-5 orders of magnitude smaller in Os complexes than in their corresponding ruthenium analogues. 11 In general, while (N,N) donor ligand containing Ru complexes typically have suitable kinetic inertness and therefore high antiproliferative activity, the corresponding Os complexes might be less active due to the above kinetic differences. On the other hand, while (O,O) chelated Ru complexes can be too labile, the Os analogues might be of the appropriate kinetic behaviour and thus exert greater biological activity. Deprotonation of the water molecule after replacing Z auxiliary ligand in aqueous solution may also result in the formation of an inactive hydroxo species, and this is more pronounced for Os than Ru complexes with a given XY chelator. 17 Since strongly coordinating XY are capable of shifting this process above pH 7.4, it is possible that Oshydroxamates might yield good potential drug candidates.
Recently we have found that reaction of [Ru(g 6 -p-cym)Cl 2 ] 2 with benzohydroxamate (Chart 1) in the presence of noncoordinating triflate counter ion produced a dinuclear complex in which two half-sandwich metal centers were linked together with two hydroxamates. In this structure the carbonyl oxygens of the bha ligands coordinate to one of the Ru units, and the hydroxamate oxygens bridge to the two Ru atoms. 8 In contrast, spectroscopic and MS results suggest that the presence of other ligands (e.g. Cl 2 ) allows monodentate coordination yielding monomeric [Ru(g 6 -p-cym)(ha)Cl] (ha = hydroxamate) type species in solution. 8 In the current study, we sought to gain deeper insight into the effect of the size of the metal ion (Ru vs. Os), the steric demand of the R C and R N substituents at the hydroxamate group, the effect of the coordination of primary (R N = H) or secondary (R N = alkyl or aryl) hydroxamate (Chart 1) and the role of any monodentate ligand (Cl 2 , pyridine) may exert on the stability, stoichiometry, nuclearity and binding architecture of the halfsandwich metal(II) hydroxamate complexes. Herein we report the syntheses, solid state characterization and X-ray structures of a series osmium and ruthenium hydroxamate complexes, together with their in vitro anti-cancer potential using human ovarian cancer cell lines (A2780 and A2780cisR). 19 N-phenylhydroxylamine hydrochloride was prepared from nitrobenzene while N-methyl-acetohydroxamic, N-phenylacetohydroxamic and N-phenyl-benzohydroxamic acid were prepared from acetyl or benzoyl chloride, by reaction with N-methyl-or N-phenylhydroxylamine following literature methods. 20 24 H-NMR spectra were recorded on a Bruker AM360 FT-NMR instrument at room temperature in (CD 3 ) 2 SO, and referenced to TMS as the internal standard. IR spectra (KBr pellets) were recorded on a Perkin Elmer FTIR Paragon 1000 PC instrument, and ESI-MS spectra (methanolic solutions) with a Bruker micrOTOF-Q 9 instrument in the positive mode. Elemental analyses (C, H, N, S) were conducted on an Elementar Variomicro Cube instrument at the Department of Organic Chemistry, Debrecen University, Hungary. DMF, all cell culture reagents and media were purchased from Sigma-Aldrich Ireland, Ltd, unless otherwise stated.
Experimental

Crystal structure analysis
Diffraction intensity data collection was carried out on a BrukerNonius MACH3 or an Agilent-Oxford SuperNova diffractometer using graphite-monochromated Mo-Ka radiation (l = 0.71073 Å ). The structures were solved by the SIR-92 program 26 and refined by full-matrix least-squares method on F 2 , with all non-hydrogen atoms refined with anisotropic thermal parameters using the SHELXL-97 package; 27 publication material was prepared with the WINGX-suite. 28 All hydrogen atoms were located geometrically, and refined using the riding model. Crystallographic and experimental details are summarized in Table 1 (2) . AgCF 3 SO 3 (102.8 mg, 0.4 mmol) was added to a solution of 1 (79.1 mg, 0.1 mmol) in dry acetone (8 mL) giving a yellow solution and an immediate precipitate of AgCl. The mixture was protected from light, stirred at r.t. for 30 min, and filtered to remove AgCl. The resulting solution was evaporated, and the brown-yellow thick oil was dried in vacuo and used in subsequent steps.
[Os(g 6 -p-cym)(methanol) 3 ](CF 3 SO 3 ) 2 (3). It was obtained as 2 using dry MeOH (10 mL). The resulting thick oil was used in subsequent steps. .
[Ru(g [Os(g 6 -p-cym)(meaha)Cl] (6). 1 (79.17 mg, 0.1 mmol) in dry MeOH (15 mL) was protected from light, stirred at r.t. for 30 min under N 2 and meahaH (35.60 mg, 0.4 mmol) and NaOMe (21.60 mg, 0.4 mmol) were added. The reaction mixture was stirred for a further 4 h. The solvent was removed by rotary evaporation, and the residue extracted with CH 2 Cl 2 . After filtering NaCl, the solution was evaporated, and the oily residue was dissolved in acetone and diethyl ether was added. On cooling at 220 uC for 24 h, yellow crystals were formed and the complex was filtered washed with diethyl ether and dried under vacuum. Yield: 48 mg (0.107 mmol, 54%). Crystals of 6 suitable for X-ray structural analysis were obtained by slow diffusion of layered diisopropyl ether in an acetone solution of the complex at 220 uC. Calcd. for C 13 [Os(g 6 -p-cym)(phebha)(py)]CF 3 SO 3 (13) . PhebhaH (170.70 mg, 0.8 mmol), NaOMe (42.50 mg, 0.8 mmol) and pyridine (0.063 mL, 0.8 mmol) were added to a solution of 2 (318.7 mg, 0.4 mmol) in dry MeOH (10 mL), protected from light, and stirred at r.t. for 3 h under N 2 . The solvent was removed by rotary evaporation, and the residue was dissolved in CH 2 Cl 2 and then filtered. To this solution, acetone and diisopropyl ether was added. Slow evaporation at 220 uC resulted in the formation of yellow crystals. The complex [Os(g 6 -p-cym)(m-OH)(py)] 2 (CF 3 SO 3 ) 2 (16 (17) . In an attempt to obtain single crystals of 4 to its solution in acetone, four fold hexane was layered and it was kept at 220 uC for 2 weeks. As no solid formed, the solution was left to evaporate to dryness at room temperature. The resulting yellow crystals of 17 were found to be directly suitable for X-ray analysis.
Cell lines and cell culture
The in vitro anti-cancer chemotherapeutic potential of test compounds was determined using two human-derived malignant ovarian cancer cell lines (A2780 and A2780cisR). Both cell lines were a kind gift from Dr Maria Morgan, Dept. of Molecular & Cellular Therapeutics, Royal College of Surgeons, Ireland, Dublin. A2780cisR cells are a cisplatin resistant human ovarian cell line developed by chronic exposure of the parent cisplatin sensitive A2780 cell line to increasing concentrations of cisplatin. Furthermore, these cells are cross-resistant to melphalan, adriamycin and irradiation. This resistant phenotype was maintained by pulsing cells during every third passage with cisplatin (1 mM). Both cell lines were maintained in RPMI-1640 media with Earle's balanced salt solution (EBSS) containing 1.5 g L 21 sodium bicarbonate, 2 mM L-glutamine, 100 U ml 21 penicillin, 100 mg ml 21 streptomycin and 10% (v/v) foetal bovine serum (FBS). These two model cell lines were grown at 37 uC in a humidified atmosphere with 5% CO 2 and were in the exponential phase of growth at the time of inclusion in cytotoxicity assays.
Assessment of cytotoxicity, using MTT assay
Each of the two cell lines (100 ml) were seeded at a density of 2. -p-cym)Cl 2 ] 2 precursors or from the coordinative unsaturated 2-3, respectively, by reacting them with the corresponding hydroxamates (see Chart 1) and with pyridine for 10-15 at room temperature. The novel compounds were air stable crystalline solids, and were soluble in polar solvents such as dichloromethane, acetone, dimethylsulfoxide, methanol and also water. The NMR spectrum of 16 indicated that three different species were formed in d 6 -DMSO solution after sample preparation using the solid crystalline complex. Selected parts of the spectrum are shown in Fig. S2 , ESI.{ DOSY experiments proved that besides free pyridine (D, Fig. S2 ), two other pyridine-containing complexes were present in solution, with three sets of signals belonging to the p-cymene protons being identifiable. Furthermore, three new singlets were also present in the spectrum which most probably belong to the hydroxide groups of the complexes. Complexes with the M(m-OH)M or M(m-OH) 2 M motif showed signals attributed to bridging OH in the 3.0-4.7 ppm range. [30] [31] [32] Therefore, the data above may suggest that after dissolution of 16, partial or complete dissociation of the coordinated pyridine ligands occurred and besides free pyridine, it is possible that intact [Os(g Electrospray ionization mass spectrometric (ESI-MS) analysis in the positive mode provided further proof for the identity of the complexes. As found previously, 8 the ESI-MS conditions produced no difference in the spectra to that of the corresponding triflate or chloride containing complexes (e.g. 4 vs. 6 or 5 vs. 7), regarding the major peaks. The same was observed with the [M(g 6 -p-cym)(ha)(py)]X complexes, revealing that chloride ion and pyridine dissociate at the ESI-MS conditions applied. All the mass spectra displayed the correct isotopic pattern.
X-ray crystallographic studies
Previously we have shown that in the presence of weakly coordinating counter ion like triflate, the primary (R N = H) hydroxamate ligand, bha [Ru(g 6 -p-cym)(m-bha)] 2 2+ indicated no significant differences in the geometry and distances in the two dinuclear structures to that of the primary or secondary hydroxamate. However, with the appropriate Os precursors, we were able to obtain a pure crystalline solid only with secondary hydroxamates (R N = alkyl, aryl). This difference between the [M(g 6 -p-cym)] 2+ (M = Ru, Os) cores can be explained by the 5d osmium(II) being more easily involved in redox reactions. 34 In particular, redox reactions with the oxidation of the metal ion by primary hydroxamates (R N = H) yielding amide has been well documented in the literature for Fe(II) or VO(IV). 35, 36 The dinuclear complex formation was disfavoured in the presence of chloride ions which are capable of stronger interaction with the half-sandwich metal cores. As demonstrated with both metals, and with different hydroxamates, two of the coordination sites of the [M(g Fig. S3 , ESI.{ The corresponding bond distances and angles (captions to Fig. 2 and S3) revealed no significant differences when the two metals or the different type hydroxamate ligands were compared. Both the Os-Cl (2.425 Å ) and the Ru-Cl (2.411 Å ) distances were shown to be in the expected range (Os: 2.40(7), Ru: 2.42(6) Å ). 37 Unexpectedly, we have found the formation of an unusual dinuclear Os complex (17) with the partial oxidation of the metal ion, when a solution of [Os(g 6 -p-cym)(meaha)] 2 (CF 3 SO 3 ) 2 (4) in a mixture of acetone/hexane, was left to evaporate slowly under aerobic conditions, and at room temperature in a narrow crystallization tube. The X-ray structure of the isolated yellow solid is presented in Fig. 3 , while the key bond angles and distances are summarized in the caption to Fig. 3 [40] [41] [42] Dinuclear complex formation can also be hindered if other monodentate ligands capable of relatively strong coordination to the half-sandwich metal cores (e.g. pyridine) are present beside the coordinating hydroxamate. As an example, the crystal structure of [Ru(g 6 -p-cym)(bha)(py)]CF 3 SO 3 (12) appears in Fig. 4 , while that of [Ru(g 6 -p-cym)(phebha)(py)]CF 3 SO 3 (14) is shown in Fig. S4 , ESI.{ In both structures, beside the hydroxamate (O,O) chelate, a pyridine N can be found in the third coordination site of the metal ion. 14 is also stabilized by Fig. 4 and S4) indicates that benzohydroxamate (R C = Phe, R N = H) and N-phenyl-benzohydroxamate (R C = R N = Phe), the latter with larger steric demand, may behave very similarly in these mixed complexes.
Although we do not have an X-ray structure of 15 with the meaha 2 ligand, the obtained analytical data are consistent with its stoichiometry. At the same time, during the synthesis of the analogous Os complex with mebhaH, we were unsuccessful in obtaining [Os(g 6 -p-cym)(mebha)(py)]CF 3 SO 3 . Instead, using 20 h reaction time and after work-up of the reaction mixture, a novel dihydroxo bridged mixed pyridine complex, 16, could be isolated and the X-ray structure determined. As Fig. 5 
Cytotoxicity in cancer cell lines
The in vitro anti-cancer chemotherapeutic potential of this series of Ru-and Os-hydroxamic acid complexes was determined using two human-derived ovarian cancer cell lines; a parental cell line (A2780) and a cisplatin-resistant variant (A2780 cisR). The results show that all the complexes (1) can be regarded as inactive (IC 50 . 200 mM), since they failed to reduce the viability of either model cell line across both the concentration range (0-200 mM) and incubation period (72 h) studied. In contrast, cisplatin displayed a significant reduction in cellular viability toward both cell lines, with mean IC 50 values of 1.3 ¡ 0.1 and 9.7 ¡ 1.0 mM seen in A2780 and A2780 cisR cells, respectively.
Conclusions
The results of this paper showed that secondary monohydroxamates (R N = alkyl, aryl) were capable of the double bridging of two half-sandwich M(II) (M = Ru, Os) cores, and the same holds true for the primary hydroxamate (R N L H) complexes of Ru. The X-ray crystal structure of 5 demonstrated that in the dinuclear entity, the two meaha 2 ligands were bound in an identical manner via deprotonated O's as bridging atoms and carbonyl O's as monodentate atoms. As [Os(g 6 -p-cym)] 2+ was less resistant to redox reactions, it was not possible to isolate stable complexes with primary hydroxamates. The presence of monodentate co-ligands resulted in the formation of mononuclear complexes with the expected [M(g 6 -p-cym)(ha)X] n+ (M = Os, Ru; ha = hydroxamate, X = py, Cl 2 ) stoichiometry, with
[Os(g 6 -p-cym)(meaha)Cl] (6), being the first organometallic Os(II)-hydroxamate characterized by X-ray crystallography. The unexpected formation of an oxo bridged dinuclear Os VI / Os II complex, 17, consisting an octahedral Os(VI) core and an 2+ core may happen under aerobic conditions. Complexes 1, 5-8, 10 and 14 were screened for possible in vitro anti-proliferative activity. Results showed that IC 50 values were greater than 200 mM. This may be explained by fast ligand exchange reactions of the (O,O) donor hydroxamates. In the case of the Os complexes, it is possible that dissociation of administered compounds, may lead to the formation of less active species which are incapable of biological activity at low concentrations. However, given that similar complexes have previously shown antimicrobial activity, additional biological studies will focus on an assessment of their anti-bacterial (Gram positive and Gram negative) and anti-fungal profile.
